A clinical pharmacological study of K-115 ophthalmic solution

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220683

Enrollment

Registered

2009-03-06

Start date

2009-03-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POAG or OH patients

Interventions

investigational material(s) Generic name etc : K-115 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.POAG or OH patients 2.Intraocular pressure(IOP) >= 21mmHg in one eye and < 30mmHg in both eyes

Exclusion criteria

Exclusion criteria: 1.Patients thought to use ophthalmic solution or ophthalmic ointment other than K-115 ophthalmic solution 2.Patients not able to stop glaucoma medication other than K-115 ophthalmic solution 3.Patients underwent ophthalmological surgery or laser surgery in the past 4.Patients not able to stop using contact lenses etc.

Design outcomes

Primary

Measure	Time frame
Efficacy, safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026